TY  - JOUR
AU  - Puig, Noemi
AU  - Contreras, Maria-Teresa
AU  - Agullo, Cristina
AU  - Martinez-Lopez, Joaquin
AU  - Oriol, Albert
AU  - Blanchard, Maria-Jesus
AU  - Rios, Rafael
AU  - Martin, Jesus
AU  - Iñigo, Maria-Belen
AU  - Sureda, Anna
AU  - Hernandez, Miguel-Teodoro
AU  - de la Rubia, Javier
AU  - Gonzalez-Calle, Veronica
AU  - Krsnik, Isabel
AU  - Cabañas, Valentin
AU  - Palomera, Luis
AU  - Moraleda, Jose-Maria
AU  - Bargay, Joan
AU  - Cedena, Maria-Teresa
AU  - Paiva, Bruno
AU  - Rosiñol, Laura
AU  - Blade, Joan
AU  - San Miguel, Jesus
AU  - Lahuerta, Juan-Jose
AU  - Mateos, Maria-Victoria
PY  - 2022
DO  - 10.1182/bloodadvances.2021006762
UR  - http://hdl.handle.net/10668/20250
T2  - Blood advances
AB  - Monitoring of the monoclonal protein (M-protein) by electrophoresis and/or immunofixation (IFE) has long been used to assess treatment response in multiple myeloma (MM). However, with the use of highly effective therapies, the M-protein becomes...
LA  - en
PB  - American Society of Hematology
KW  - Antibodies, Monoclonal
KW  - Immunoglobulin Light Chains
KW  - Transplantation, Autologous
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Mass Spectrometry
KW  - Multiple Myeloma
TI  - Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma.
TY  - research article
VL  - 6
ER  -